Maternal mortality in pregnant women with positive SARS-CoV-2 antibodies and severe preeclampsia. Report of 3 cases

• Autores: Collantes Cubas, Jorge Arturo, Pérez Ventura, Segundo Alberto, Vigil - De Gracia, Paulino, Castañeda Bazán, Karla Esperanza, Tapia Saldaña, Juan Martín, Leyva, Francisco Jose
• Formato: artículo
• Fecha de Publicación: 2020
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista SPOG - Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español; inglés
• OAI Identifier: oai:ojs.spog:article/2279
• Enlace del recurso: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/2279
• Nivel de acceso: acceso abierto
• Materia: Maternal mortality; Preeclampsia; Eclampsia; HELLP syndrome; COVID-19; Stroke; Diabetes mellitus; Mortalidad materna; Preeclampsia; Eclampsia; Síndrome HELLP; COVID-19; Accidente cerebrovascular; Diabetes mellitus

Maternal mortality from COVID-19 is rare in developed countries, but its association with other obstetric complications increases the risk. It is also associated with fetal death. Postpartum women are at risk of thrombosis that increases with COVID-19 coagulopathy. Comorbidities such as obesity, diabetes, and hypertension increase the risk of death from COVID-19, and pregnant women have more complications during the third trimester than in the first trimester, with higher risk than nonpregnant women of entering the ICU and requiring mechanical ventilation. In this report, stroke, diabetes and intracerebral hemorrhage were the three causes of death described, all within the context of stillbirth, severe preeclampsia, eclampsia and/or HELLP syndrome.